Showing results (91-100 of 274) with videos related to

Sort By:
Pageof 28
Current Drug Targets|August 5, 2015
Molecular Pharmacology of Malignant Pleural Mesothelioma: Challenges and Perspectives From Preclinical and Clinical StudiesStefano Thellung, Roberto E Favoni, Roberto Würth, et al.
Cells|May 13, 2026
Microglia Reprogramming in Glioblastoma: Stem Cell-Derived Factors as Emerging ImmunomodulatorsZahra Amiri, Beatrice Federica Tremonti, Alessandro Corsaro, et al.
Journal of Virological Methods|November 27, 2019
Evaluation of a molecular method for hepatitis E virus (HEV) detection in pancreatin of porcine originPaola Modesto, Maria Grazia Maniaci, Umberto Cavallazzi, et al.
Neuro-Oncology|April 19, 2023
Stem-like signatures in human meningioma cells are under the control of CXCL11/CXCL12 chemokine activityFederica Barbieri, Adriana Bajetto, Irene Dellacasagrande, et al.
The International Journal of Biochemistry & Cell Biology|November 25, 2010
High hydrophobic amino acid exposure is responsible of the neurotoxic effects induced by E200K or D202N disease-related mutations of the human prion proteinAlessandro Corsaro, Stefano Thellung, Tonino Bucciarelli, et al.
Glia|August 21, 2007
ERK1/2 and p38 MAP kinases control prion protein fragment 90-231-induced astrocyte proliferation and microglia activationStefano Thellung, Valentina Villa, Alessandro Corsaro, et al.
Molecular Neurobiology|July 8, 2018
Effects of Prion Protein on Aβ42 and Pyroglutamate-Modified AβpΕ3-42 Oligomerization and ToxicityKatiuscia Pagano, Denise Galante, Cristina D'Arrigo, et al.
Pageof 28